LASP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.909800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.879600E-01
Normal-vs-Stage2
7.119800E-01
Normal-vs-Stage3
8.022600E-01
Normal-vs-Stage4
5.286400E-01
Stage1-vs-Stage2
3.197600E-01
Stage1-vs-Stage3
6.033800E-01
Stage1-vs-Stage4
3.467600E-01
Stage2-vs-Stage3
9.648200E-01
Stage2-vs-Stage4
8.768800E-01
Stage3-vs-Stage4
9.751000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.370200E-01
Normal-vs-AfricanAmerican
4.024800E-01
Normal-vs-Asian
3.531800E-01
Caucasian-vs-AfricanAmerican
6.696200E-01
Caucasian-vs-Asian
4.776200E-01
AfricanAmerican-vs-Asian
7.338000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.670600E-01
Normal-vs-Female
8.292600E-01
Male-vs-Female
7.241600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.942200E-01
Normal-vs-Age(41-60Yrs)
3.265600E-01
Normal-vs-Age(61-80Yrs)
7.691600E-01
Normal-vs-Age(81-100Yrs)
7.702600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.395960E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.630800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.703600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.758100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.245600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.665600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.341800E-01
Normal-vs-Daily Drinker
8.025400E-01
Normal-vs-Weekly Drinker
9.546000E-01
Normal-vs-Occasional Drinker
4.923800E-01
Normal-vs-Social Drinker
6.532600E-01
Non Drinker-vs-Daily Drinker
5.285200E-01
Non Drinker-vs-Weekly Drinker
9.469400E-01
Non Drinker-vs-Occasional Drinker
3.260400E-01
Non Drinker-vs-Social Drinker
6.618000E-01
Daily Drinker-vs-Weekly Drinker
6.004000E-01
Daily Drinker-vs-Occasional Drinker
8.228000E-02
Daily Drinker-vs-Social Drinker
2.378600E-01
Weekly Drinker-vs-Occasional Drinker
3.071200E-01
Weekly Drinker-vs-Social Drinker
5.956800E-01
Occasional Drinker-vs-Social Drinker
5.576400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.943650E-01
Normal-vs-Grade 2
5.016000E-02
Normal-vs-Grade 3
5.860400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.120200E-02
Grade 1-vs-Grade 3
1.778410E-02
Grade 1-vs-Grade 4
1.943650E-01
Grade 2-vs-Grade 3
3.313600E-01
Grade 2-vs-Grade 4
5.016000E-02
Grade 3-vs-Grade 4
5.860400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.568800E-01
Normal-vs-NonDiabetic
6.905600E-01
Diabetic-vs-NonDiabetic
3.346200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.450770E-01
Normal-vs-NoPancreatitis
8.784000E-01
Pancreatitis-vs-NoPancreatitis
3.777600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.331600E-01
Normal-vs-N1
7.270400E-01
N0-vs-N1
2.140800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.680100E-03
Normal-vs-TP53-NonMutant
2.073200E-01
TP53-Mutant-vs-TP53-NonMutant
6.27119999999648E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
